MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Daun02

CAS No. : 290304-24-4

MCE 站：Daun02

产品活性：Daun02是拓扑异构酶抑制剂Daunorubicin的前药。

研究领域：Cell Cycle/DNA Damage  |  Antibody-drug Conjugate/ADC Related

作用靶点：Topoisomerase  |  ADC Cytotoxin

In Vitro: Daun02 is a prodrug, which is converted by β-galactosidase to Daunorubicin, which has been shown to reduce calcium ion (Ca²⁺)-dependent action potentials in neuroblastoma cells. Daunorubicin is a topoisomerase inhibitor. Daun02 is a good substrate for β-galactosidase (β-gal). The concentration of Daun02 producing 50% (EC₅₀) decrease in cell viability is 0.5 μM, 1.5 μM, and 3.5 μM for T47-D, Panc02, and MCF-7, respectively.

In Vivo: Daun02 is a good substrate for β-gal with K_m and V_max values of 0.37 mM and 8.6 μmol/min/mg protein. At a concentration of 10^-5 M, Daun02 is 79% bound to plasma protein compares to 94% for Daunomycin.

相关产品：Natural Product Like Compound Library  |  Bioactive Compound Library Plus  |  Cell Cycle/DNA Damage Compound Library  |  Toxins for Antibody-Drug Conjugate Research Library  |  Anti-Cancer Compound Library  |  Anti-Aging Compound Library  |  Doxorubicin hydrochloride  |  Paclitaxel  |  Etoposide  |  Mitomycin C  |  Methotrexate  |  Irinotecan  |  SN-38  |  Camptothecin  |  Topotecan Hydrochloride  |  Epirubicin hydrochloride  |  Daunorubicin hydrochloride  |  Exatecan mesylate  |  Mertansine  |  Suramin sodium salt  |  Berberine chloride  |  Mitoxantrone  |  Betulinic acid  |  EIDD-1931  |  Idarubicin hydrochloride  |  Aldoxorubicin  |  D8-MMAE  |  Banoxantrone dihydrochloride  |  Calicheamicin  |  β-Lapachone  |  Teniposide

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。